Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Agafonov

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Chemico-Biological Interactions|November 30, 2018
Interaction of the anti-tuberculous drug bedaquiline with artificial membranes and rat erythrocytesKonstantin N Belosludtsev, Nikita V Penkov, Kirill S Tenkov, et al.
ACS Chemical Biology|September 28, 2021
Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen-Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based DesignScott J Eron, Hongwei Huang, Roman V Agafonov, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
RSC Medicinal Chemistry|August 18, 2025
Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degraderDouglas L Orsi, Kiel E Lazarski, Reina Improgo, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Chemico-Biological Interactions|November 30, 2018
Interaction of the anti-tuberculous drug bedaquiline with artificial membranes and rat erythrocytesKonstantin N Belosludtsev, Nikita V Penkov, Kirill S Tenkov, et al.
ACS Chemical Biology|September 28, 2021
Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen-Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based DesignScott J Eron, Hongwei Huang, Roman V Agafonov, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
RSC Medicinal Chemistry|August 18, 2025
Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degraderDouglas L Orsi, Kiel E Lazarski, Reina Improgo, et al.
Pageof 13